跳至主要内容
临床试验/ACTRN12626000987369
ACTRN12626000987369进行中(未招募)不适用

Exercise as a therapeutic tool for the attenuation of physical function loss and change in health outcomes for people living with Systemic Sclerosis.

St Vincent's Institute of Medical Research0 个研究点目标入组 28 人开始时间: 2027年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Other
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 No limit(—)
性别
All

入选标准

  • Males and females with a confirmed American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) classification of SSc
  • Aged 18+ years
  • Fluent in the English language

排除标准

  • Absolute contraindication to exercise
  • Inability to cycle on an upright bike
  • Renal impairment (eGFR <30mL/min/1.73m2)
  • Pulmonary Arterial Hypertension
  • Current Atrial Fibrillation
  • Heart failure and/or LVEF <50%
  • Severe ILD defined as Forced Vital Capacity (FVC) <45% (predicted), single-breath carbon monoxide diffusing lung capacity (DLCO) corrected for haemoglobin <30% (predicted)
  • Contraindication to MRI (pacemaker, defibrillator or any implanted foreign body, severe claustrophobia)
  • Pregnancy or currently breastfeeding
  • Gadolinium allergy

研究者

相似试验